Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 182

1.

Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience.

Burman J, Iacobaeus E, Svenningsson A, Lycke J, Gunnarsson M, Nilsson P, Vrethem M, Fredrikson S, Martin C, Sandstedt A, Uggla B, Lenhoff S, Johansson JE, Isaksson C, Hägglund H, Carlson K, Fagius J.

J Neurol Neurosurg Psychiatry. 2014 Oct;85(10):1116-21. doi: 10.1136/jnnp-2013-307207. Epub 2014 Feb 19.

PMID:
24554104
[PubMed - in process]
2.

Radiologically isolated syndrome: an uncommon finding at a university clinic in a high-prevalence region for multiple sclerosis.

Granberg T, Martola J, Aspelin P, Kristoffersen-Wiberg M, Fredrikson S.

BMJ Open. 2013 Nov 4;3(11):e003531. doi: 10.1136/bmjopen-2013-003531.

PMID:
24189079
[PubMed]
Free PMC Article
3.

A 10-year follow-up of a population-based study of people with multiple sclerosis in Stockholm, Sweden: changes in disability and the value of different factors in predicting disability and mortality.

Chruzander C, Johansson S, Gottberg K, Einarsson U, Fredrikson S, Holmqvist LW, Ytterberg C.

J Neurol Sci. 2013 Sep 15;332(1-2):121-7. doi: 10.1016/j.jns.2013.07.003. Epub 2013 Jul 26.

PMID:
23896259
[PubMed - indexed for MEDLINE]
Free Article
4.

Reports of patients and relatives from the CogniCIS study about cognition in clinically isolated syndrome: what are our patients telling us?

Langdon DW, Benedict RH, Wicklein EM, Beckmann K, Fredrikson S.

Eur Neurol. 2013;69(6):346-51. doi: 10.1159/000345698. Epub 2013 Apr 26.

PMID:
23635720
[PubMed - indexed for MEDLINE]
5.

A cost-effectiveness analysis of subcutaneous interferon beta-1a 44mcg 3-times a week vs no treatment for patients with clinically isolated syndrome in Sweden.

Fredrikson S, McLeod E, Henry N, Pitcher A, Lowin J, Cuche M, Fajutrao L, Perard R, Bates D, Chan A.

J Med Econ. 2013;16(6):756-62. doi: 10.3111/13696998.2013.792824. Epub 2013 Apr 17.

PMID:
23556422
[PubMed - indexed for MEDLINE]
6.

Differences between users and non-users of complementary and alternative medicine among people with multiple sclerosis in Denmark: a comparison of descriptive characteristics.

Skovgaard L, Nicolajsen PH, Pedersen E, Kant M, Fredrikson S, Verhoef M, Meyrowitsch D.

Scand J Public Health. 2013 Jul;41(5):492-9. doi: 10.1177/1403494813481646. Epub 2013 Apr 2.

PMID:
23548494
[PubMed - indexed for MEDLINE]
7.

The utility of cerebrospinal fluid analysis in patients with multiple sclerosis.

Stangel M, Fredrikson S, Meinl E, Petzold A, Stüve O, Tumani H.

Nat Rev Neurol. 2013 May;9(5):267-76. doi: 10.1038/nrneurol.2013.41. Epub 2013 Mar 26. Review.

PMID:
23528543
[PubMed - indexed for MEDLINE]
8.

Use of Complementary and Alternative Medicine among People with Multiple Sclerosis in the Nordic Countries.

Skovgaard L, Nicolajsen PH, Pedersen E, Kant M, Fredrikson S, Verhoef M, Meyrowitsch DW.

Autoimmune Dis. 2012;2012:841085. doi: 10.1155/2012/841085. Epub 2012 Dec 11.

PMID:
23304461
[PubMed]
Free PMC Article
9.

Cost-minimization analysis of fingolimod compared with natalizumab for the treatment of relapsing-remitting multiple sclerosis in Sweden.

Bergvall N, Tambour M, Henriksson F, Fredrikson S.

J Med Econ. 2013;16(3):349-57. doi: 10.3111/13696998.2012.755537. Epub 2012 Dec 18.

PMID:
23211038
[PubMed - indexed for MEDLINE]
10.

Time to secondary progression in patients with multiple sclerosis who were treated with first generation immunomodulating drugs.

Tedeholm H, Lycke J, Skoog B, Lisovskaja V, Hillert J, Dahle C, Fagius J, Fredrikson S, Landtblom AM, Malmeström C, Martin C, Piehl F, Runmarker B, Stawiarz L, Vrethem M, Nerman O, Andersen O.

Mult Scler. 2013 May;19(6):765-74. doi: 10.1177/1352458512463764. Epub 2012 Nov 1.

PMID:
23124789
[PubMed - in process]
Free PMC Article
11.

[How MS was discovered in Sweden].

Ahremark G, Fredrikson S.

Lakartidningen. 2012 Sep 19-26;109(38):1688-90. Swedish. No abstract available.

PMID:
23094402
[PubMed - indexed for MEDLINE]
12.

Callosal atrophy in multiple sclerosis is related to cognitive speed.

Bergendal G, Martola J, Stawiarz L, Kristoffersen-Wiberg M, Fredrikson S, Almkvist O.

Acta Neurol Scand. 2013 Apr;127(4):281-9. doi: 10.1111/ane.12006. Epub 2012 Sep 18.

PMID:
22988936
[PubMed - indexed for MEDLINE]
13.

Interferon β for secondary progressive multiple sclerosis: a systematic review.

Mantia LL, Vacchi L, Rovaris M, Di Pietrantonj C, Ebers G, Fredrikson S, Filippini G.

J Neurol Neurosurg Psychiatry. 2013 Apr;84(4):420-6. doi: 10.1136/jnnp-2012-303291. Epub 2012 Sep 5. Review.

PMID:
22952326
[PubMed - indexed for MEDLINE]
14.

Brief International Cognitive Assessment for MS (BICAMS): international standards for validation.

Benedict RH, Amato MP, Boringa J, Brochet B, Foley F, Fredrikson S, Hamalainen P, Hartung H, Krupp L, Penner I, Reder AT, Langdon D.

BMC Neurol. 2012 Jul 16;12:55. doi: 10.1186/1471-2377-12-55.

PMID:
22799620
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Radiologically isolated syndrome--incidental magnetic resonance imaging findings suggestive of multiple sclerosis, a systematic review.

Granberg T, Martola J, Kristoffersen-Wiberg M, Aspelin P, Fredrikson S.

Mult Scler. 2013 Mar;19(3):271-80. doi: 10.1177/1352458512451943. Epub 2012 Jul 3. Review.

PMID:
22760099
[PubMed - indexed for MEDLINE]
16.

[The Swedish Neurological Association: The number of neurologists need to double over the next decade].

Remahl IN, Fredrikson S, Gunnarsson M, Hietala A, Stridh L, Jood K, Burman J, Johansson R, Jensen SM, Petersson J, Zarrinkobb L, Smits A.

Lakartidningen. 2012 May 9-15;109(19):970. Swedish. No abstract available.

PMID:
22734265
[PubMed - indexed for MEDLINE]
17.

Multiple sclerosis in Pakistan: histocompatibility antigen composition and disability.

Wasay M, Moatter T, Mehmood K, Subhan M, Ahmed A, Tariq M, Khoso N, Shahbaz N, Awan S, Fredrikson S.

Mult Scler. 2013 Feb;19(2):254-5. doi: 10.1177/1352458512450356. Epub 2012 Jun 8. No abstract available.

PMID:
22685063
[PubMed - indexed for MEDLINE]
18.

Cost-effectiveness analysis of interferon beta-1b for the treatment of patients with a first clinical event suggestive of multiple sclerosis.

Caloyeras JP, Zhang B, Wang C, Eriksson M, Fredrikson S, Beckmann K, Knappertz V, Pohl C, Hartung HP, Shah D, Miller JD, Sandbrink R, Lanius V, Gondek K, Russell MW.

Clin Ther. 2012 May;34(5):1132-44. doi: 10.1016/j.clinthera.2012.03.004. Epub 2012 Apr 27.

PMID:
22541587
[PubMed - indexed for MEDLINE]
19.

Interferon beta for secondary progressive multiple sclerosis.

La Mantia L, Vacchi L, Di Pietrantonj C, Ebers G, Rovaris M, Fredrikson S, Filippini G.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD005181. doi: 10.1002/14651858.CD005181.pub3. Review.

PMID:
22258960
[PubMed - indexed for MEDLINE]
20.

Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS).

Langdon DW, Amato MP, Boringa J, Brochet B, Foley F, Fredrikson S, Hämäläinen P, Hartung HP, Krupp L, Penner IK, Reder AT, Benedict RH.

Mult Scler. 2012 Jun;18(6):891-8. doi: 10.1177/1352458511431076. Epub 2011 Dec 21. Review.

PMID:
22190573
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk